new
   Indications for Dasatinib (Sprycel)
502
Nov 03, 2025

Dasatinib (Sprycel) is a multi-targeted inhibitor against tyrosine kinases, which exerts anti-cancer effects by blocking multiple key tumor signaling pathways. With its unique "dual mechanism", it can not only act on the active conformation of ABL kinase but also bind to the inactive conformation, thereby effectively overcoming a variety of imatinib-resistant mutations.

Indications for Dasatinib (Sprycel)

Indications for Adult Patients

Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.

Patients with chronic phase, accelerated phase, or blast phase (myeloid or lymphoid) CML who are resistant or intolerant to previous treatments (including imatinib).

Patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who are resistant or intolerant to previous treatments.

Indications for Pediatric Patients (Children Aged 1 Year and Older)

Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.

Newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL), which needs to be used in combination with chemotherapy.

Specifications and Properties of Dasatinib (Sprycel)

Appearance Characteristics

All tablets are white to off-white, biconvex, film-coated tablets.

20 mg: Round tablets, engraved with "BMS" on one side and "527" on the other side.

50 mg: Oval tablets, engraved with "BMS" on one side and "528" on the other side.

100 mg: Oval tablets, engraved with "BMS100" on one side and "852" on the other side.

The tablet core contains the active ingredient dasatinib, and the outer layer is coated with a film to reduce the risk of exposure for healthcare workers.

Storage Conditions for Dasatinib (Sprycel)

General Storage Requirements

Storage temperature: 20°C to 25°C (68°F to 77°F).

Short-term storage in an environment of 15°C to 30°C (59°F to 86°F) is permitted.

Precautions for Special Operations

Prohibition of crushing operations: Tablets must not be crushed, split, or chewed; they must be swallowed whole.

Safety Protection Measures

Latex or nitrile gloves must be worn when handling crushed tablets.

Pregnant individuals should avoid contact with broken tablets.

Special disposal procedures must be followed when discarding expired medications.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Dosage and Administration, Recommended Dose of Elacestrant (Orserdu)

Elacestrant (Orserdu) is a selective estrogen receptor degrader (SERD), which provides an important treatment option...

Friday, December 19th, 2025, 11:49
What Are the Indications for Elacestrant (Orserdu)?

Elacestrant (Orserdu) is a novel endocrine therapy agent that demonstrates significant value in the treatment of...

Friday, December 19th, 2025, 11:40
What Are the Purchase Channels for Elacestrant (Orserdu)?

With the advancement of medical technology, elacestrant (Orserdu), a targeted drug for breast cancer with specific...

Friday, December 19th, 2025, 11:38
Adverse Reactions of Capmatinib (Tabrecta)

Capmatinib (Tabrecta) is a highly selective MET inhibitor indicated for the treatment of patients with advanced...

Friday, December 19th, 2025, 11:35
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved